As per the latest The Insight Partners research report, "Pharmaceutical Robots Market to 2028 – Global Analysis and Forecast – by Product, Application, End User, and Geography," the market is projected to reach US$ 383.91 million by 2028 from US$ 159.23 million in 2021; it is expected to grow at a CAGR of 13.4% during 2021–2028. The market growth is mainly attributed to benefits offered by robots in pharmaceutical manufacturing, growing awareness of robotic systems in manufacturing process, increasing investments in pharmaceutical research and development.
Traditional Robots Held the Largest Share by Product Segment in Pharmaceutical Robots Market During 2021–2028
In 2020, North America dominated the global pharmaceutical robots market. The growth of the market is majorly defined by the rise of robot density in overall industrial applications in the US. For instance, according to the International Federation of Robotics, robot density in the United States increased significantly to 189 robots in 2016 making it seventh largest in the world. Moreover, high growth of pharmaceutical industry and availability of technologically advanced facilities in the region of research, and development are also likely to augment the Pharmaceutical Robots Market growth of the region. Also, strategic activities by the manufactures will further offer lucrative opportunities in the review period. For instance, in Mar 2021, Yaskawa Electric Corporation launched a new hybrid Yaskawa cobot-MOTOMAN HC10DTF for food and pharmaceutical industries. The MOTOMAN HC10DTF fulfils the stringent hygienic requirements of the food and pharmaceutical industry pursuant to ISO Class 5 or EG-GMP Class A.
The COVID-19 pandemic has disrupted the socio-economic conditions of various countries across the world. As the epidemic has become a global pandemic, AI tools and technologies can be used to support policymakers, the medical community, and society to manage every stage of the crisis and its aftermath: detection, prevention, response, recovery, and acceleration of research. Artificial intelligence plays a crucial role in preventing the Covid-19 pandemic. In August 2020, the National Institutes of Health launched the Medical Imaging and Data Resource Center (MIDRC) to use artificial intelligence in medical imaging to fight COVID-19. The collaboration was headed by the National Institute of Biomedical Imaging and Bioengineering (NIBIB), part of NIH, which will develop new methods that physicians can use for early discovery and personalized therapies for COVID-19 patients. Covid-19 has tremendously increased awareness of the benefits of automation within the pharmaceutical industry. In this pandemic, it is important to increase pharmaceutical production without compromising quality and safety. Flexible, modular automation enables pharmaceutical companies to increase production safely and to build lines faster and in a more scalable way. As per the Robotic Industries Association (RIA), a group focused on the robotics industry, orders for robots from the North American life sciences companies increased by 69% in 2020 compared to 2019.
Benefits Offered by Robots in Pharmaceutical Manufacturing Fuels Pharmaceutical Robots Market Growth
In recent years, there have been considerable developments in the field of robotics. Robotics offers automation in various pharmaceutical manufacturing processes, such as filling, packaging, and inspection. A few benefits of automation in pharmaceutical manufacturing are improving efficiency in manufacturing, decreasing labor cost, reducing time used for training labors, protecting employees from a hazardous environment, and eliminating the chances of human errors and human contamination. Selective Compliance Assembly Robot Arm (SCARA) robots are used for common pick and place operations. Delta robots are also preferred for high-speed picking and packaging. Parallel robots are used for dispensing, kit assembly, sorting, and light machine tending applications. The pharmaceutical industry has realized the potential of robots for diverse applications in the manufacturing process. Merck employed a FANUC M-1iA delta robot on a bottling line, which places dispenser caps onto bottled allergy medications. FANUC M16iB is also used by laboratories for processing vials. Robots have the potential to handle 10 vials at a time, which increa...
(All Rights Reserved)